(Reuters) – CVS Health Corp on Tuesday raised its adjusted earnings forecast for 2021, citing strong retail sales helped by higher demand for COVID-19 vaccines as well as over-the-counter testing in November and December.
The company, best known for its chain of drugstores, raised its forecast for 2021 adjusted profit per share to a range of $8.33 to $8.38, up from at least $8.00 previously.
(Reporting by Ankur Banerjee and Manojna Maddipatla in Bengaluru; Editing by Ramakrishnan M.)